Publication | Open Access
Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas
35
Citations
27
References
2022
Year
This real-world study provides evidence of the activity of cabozantinib in TRCC, with more durable responses than those observed historically with other VEGFR-TKIs or ICIs.
| Year | Citations | |
|---|---|---|
Page 1
Page 1